RG7155, a humanized monoclonal antibody of CSF-1R, strikingly reduces the CSF-1R+CD163+ macrophage infiltration in patients with diffuse-type giant cell tumor and increases CD8+ T cells and NK cells in tumor tissues (Ries et al., 2014). Here, CSF1R is linked to tenosynovial giant cell tumor, diffuse type.